Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.
Shared 1 month ago
40 views
Shared 3 months ago
108 views
Shared 4 months ago
58 views
Shared 4 months ago
76 views
Shared 6 months ago
34 views
Shared 6 months ago
28 views
Shared 7 months ago
16 views
Shared 7 months ago
21 views
Shared 7 months ago
27 views
Shared 1 year ago
50 views
Shared 1 year ago
28 views
Shared 2 years ago
45 views